The healthcare professional networking and data company said the deal will give its users access to the latest research in biology and medicine.
Experts on a panel hosted by the Digital Medicine Society and the Consumer Technology Association discuss how healthcare organizations can utilize artificial intelligence without amplifying inequities.
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.
